10-Q: Natural Health Trends Corp. Reports First Quarter 2024 Results

Natural Health Trends Corp. reports a decrease in net sales and a slight decrease in net income for the first quarter of 2024 compared to the same period last year.

Summary

• Natural Health Trends Corp. reported net sales of $10.951 million for the first quarter of 2024, a decrease from $11.861 million in the same period of 2023.
• The company's net income for the quarter was $188,000, down from $257,000 in the first quarter of 2023.
• The decrease in sales was primarily attributed to a decline in Hong Kong sales, which are substantially derived from sales to members in China, and a decrease in sales in other geographic markets.
• The company's gross profit margin decreased slightly to 73.4% from 74.5% due to higher costs related to the Premium Noni Juice product.
• Commissions expense decreased slightly as a percentage of net sales to 41.0% from 42.1% due to lower weekly commissions earned outside of Hong Kong.
• Selling, general, and administrative expenses decreased to $3.9 million from $4.2 million due to lower employee-related costs and professional fees.
• Other income decreased to $563,000 from $681,000 due to foreign currency gains in the prior year that did not reoccur.
• The company's cash, cash equivalents, and marketable securities totaled $54.4 million as of March 31, 2024.
• The company paid cash dividends of $0.20 per common share during the first quarter of 2024, totaling $2.3 million.
• The company had 31,620 active members as of March 31, 2024, compared to 32,410 at December 31, 2023 and 38,330 at March 31, 2023.

Sentiment

Score: 4

Explanation: The sentiment is negative due to decreased sales and net income, along with a decline in active members. However, the company maintains a strong cash position and is taking steps to address challenges in key markets.

Positives

• The company's operating cash flow improved to $549,000 in Q1 2024 compared to a cash outflow of $696,000 in Q1 2023.
• Selling, general and administrative expenses decreased due to lower employee-related costs and professional fees.
• The company maintains a strong working capital position with $41.9 million as of March 31, 2024.
• The company has $21.9 million remaining under its stock repurchase program.

Negatives

• Net sales decreased by 8% year-over-year.
• Net income decreased by 27% year-over-year.
• Gross profit margin decreased slightly.
• The number of active members decreased year-over-year.
• Other income decreased due to foreign currency fluctuations.
• Hong Kong sales, which are substantially derived from sales to members in China, decreased by 5% year-over-year.

Risks

• The company's Hong Kong operations, which account for a substantial portion of its business, are subject to political and social developments in Hong Kong and China.
• The company's business is subject to various laws and regulations, particularly those related to direct selling activities.
• The company's business is subject to risks related to product concentration and lack of revenue diversification.
• The company's business is subject to the risk of adverse publicity associated with its products or network marketing program.
• The company's business is subject to the risk of unfavorable economic and market conditions and the uncertain geopolitical environment.
• The company's business is subject to the risk of epidemics, such as the COVID-19 pandemic, or natural disasters, terrorist attacks or acts of war.
• The company's business is subject to the risk of high competition in the industry.
• The company's business is subject to the risk of failure of new products to gain member and market acceptance.
• The company relies on a limited number of third parties to manufacture and supply its products.
• The company's growth may be impeded by the political and economic risks of operating in foreign markets.
• The company's business is subject to the risk of failure to maintain effective internal controls.
• The company's business is subject to the risk of management changes or an inability to attract and retain key personnel.
• The company's business is subject to the risk of improper member actions that violate laws or regulations.
• The company's business is subject to the risk of an increase in the amount of compensation paid to members.
• The company's business is subject to the risk of being held responsible for certain taxes or assessments relating to the activities of its members and service providers.
• The company's business in China is subject to compliance with a myriad of applicable laws and regulations.
• The company's business is subject to the risk of changes in government trade and economic policies.
• The company's business is subject to the risk of direct-selling laws and regulations.
• The company's business is subject to the risk of privacy, data protection and information security laws and regulations.
• The company's business is subject to the risk of challenges by third parties to the legality of its business operations.
• The company's business is subject to the risk of lawsuits, claims, and governmental proceedings and inquiries.
• The company's business is subject to the risk of currency exchange rate fluctuations.
• The company's business is subject to the risk of changes in tax or duty laws.
• The company's business is subject to the risk of transfer pricing regulations.
• The company's products and related activities are subject to extensive government regulation.
• The company's business is subject to the risk of new regulations governing the marketing and sale of nutritional supplements.
• The company's business is subject to the risk of regulations governing the production and marketing of personal care products.
• The company's business is subject to the risk of not being in compliance with good manufacturing practices.
• The company's business is subject to the risk of failure to comply with domestic and foreign laws and regulations governing product claims and advertising.
• The company's business is subject to anti-bribery laws, including the U.S. Foreign Corrupt Practices Act.
• The company does not have a comprehensive product liability insurance program.
• The company may be unable to protect or use its intellectual property rights.
• The company relies on and is subject to risks associated with its reliance upon information technology systems.
• The company's systems, software and data reside on third-party servers.
• The company's common stock is particularly subject to volatility.
• The company's common stock continues to experience wide fluctuations in trading volumes and prices.

Future Outlook

The company expects to continue paying a quarterly cash dividend of $0.20 on each share of common stock outstanding for the foreseeable future, but any future cash dividends will be at the sole discretion of the company's Board of Directors. The company believes that its existing internal liquidity, supported by cash on hand and cash flows from operations, should be adequate to fund normal business operations and address its financial commitments for the foreseeable future. The company will continue to invest in its Mainland China entity for such purposes as establishing China-based manufacturing capabilities, increasing public awareness of its brand and products, sourcing more Chinese-made products, building a chain of service stations, opening additional Healthy Lifestyle Centers or branch offices, adding local staffing and other requirements for a prospective China direct selling license application.

Management Comments

• The company's priority is to focus resources in its most promising markets, which are considered to be Greater China and countries where existing members have connections to recruit prospects and sell products.
• The company is continually evaluating its business for compliance with applicable laws and regulations.
• The company expects to reapply for a direct selling license in China when it believes that circumstances are again ripe for doing so.
• The company believes that the 100-day campaign in China, as well as its extension and aftermath, will continue to negatively impact its business in China in the near-term, but will ultimately benefit the company and Chinese consumers in the long-term.
• The company is hopeful that it will continue to normalize operations in China and Hong Kong.

Industry Context

The direct selling industry is facing challenges in China due to regulatory scrutiny and negative media coverage. The company's performance is also impacted by the ongoing political and social developments in Hong Kong and the lingering effects of the COVID-19 pandemic. The company is adapting its marketing programs and focusing on its most promising markets to navigate these challenges.

Comparison to Industry Standards

• The company's revenue decline of 8% is worse than some of its peers in the direct selling industry, which have shown more resilience in the face of regulatory challenges in China.
• The company's gross profit margin of 73.4% is within the typical range for direct selling companies, but there are some companies with higher margins due to different product mixes and cost structures.
• The company's commission expense as a percentage of net sales at 41.0% is comparable to other direct selling companies, but some companies may have higher or lower commission rates depending on their compensation plans.
• The company's cash position of $54.4 million is relatively strong compared to some smaller direct selling companies, but it is lower than some of the larger players in the industry.
• The company's active member count of 31,620 is lower than some of its competitors, indicating a need to focus on member recruitment and retention.

Related Party Transactions

• The company has a Royalty Agreement and License with Broady Health Sciences, L.L.C. (BHS) regarding the manufacture and sale of a product called ReStor. George K. Broady, a former director of the Company and beneficial owner of more than 5% of its outstanding common stock, is an indirect owner of BHS. Brunde E. Broady, also a former director of the Company and daughter of Mr. Broady, is the President and Chief Executive Officer of BHS. The company recognized royalties of $9,000 and $11,000 during the three months ended March 31, 2024 and 2023, respectively, under this agreement.

Stakeholder Impact

• Shareholders may be concerned about the decrease in net sales and net income.
• Employees may be affected by the company's cost-cutting measures.
• Members may be impacted by changes in the company's compensation plan or marketing programs.
• Customers may be affected by changes in the company's product offerings or pricing.
• Suppliers may be impacted by changes in the company's purchasing patterns.
• Creditors may be concerned about the company's financial performance.

Next Steps

• The company will continue to invest in its Mainland China entity for such purposes as establishing China-based manufacturing capabilities, increasing public awareness of its brand and products, sourcing more Chinese-made products, building a chain of service stations, opening additional Healthy Lifestyle Centers or branch offices, adding local staffing and other requirements for a prospective China direct selling license application.
• The company will continue to evaluate its business for compliance with applicable laws and regulations.
• The company will continue to focus resources in its most promising markets.

Key Dates

Keywords

direct selling, e-commerce, personal care, wellness, network marketing, China, Hong Kong, member, commissions, NHT Global